Coviracil

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2003
01219992003

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
OBJECTIVE To review the pharmacology, virology, pharmacokinetics, safety, and efficacy of the nucleoside reverse transcriptase… (More)
Is this relevant?
Review
2004
Review
2004
HIV encodes an RNA directed DNA polymerase (reverse transcriptase, RT) that is an essential enzyme in the viral replication cycle… (More)
Is this relevant?
2003
2003
  • Project Inform perspective
  • 2003
The most significant new information about anti-HIV drugs offered in Barcelona concerned those drugs that are either already… (More)
Is this relevant?
Review
2003
Review
2003
  • Drugs in R&D
  • 2003
 
Is this relevant?
2001
2001
Antiretroviral monotherapy for initial drug characterization risks the selection of resistant virus, yet monotherapy is the only… (More)
Is this relevant?
2000
2000
  • The AIDS reader
  • 2000
 
Is this relevant?
Review
2000
Review
2000
NATURE | VOL 404 | 13 APRIL 2000 | www.nature.com 695 Munich Applying for research grants is always a complicated and time… (More)
Is this relevant?
2000
2000
Triangle Pharmaceuticals has licensed the development rights to emtricitabine (FTC), an antiviral nucleoside analog that is… (More)
Is this relevant?
1999
1999
  • Project Inform perspective
  • 1999
Updates are provided for new anti-HIV drugs currently in development. ABT-378, Tipranavir, and DMP-450 are among the new protease… (More)
Is this relevant?